Research program identifying molecular targets for plant probiotics containing Plant Growth-Promoting Rhizobacteria (PGPR) to combat fungal root rot in Vicia faba L. Previous field trials demonstrated 29-45% yield increases. Next phase investigates PGPR-mediated disease resistance against S. Sclerotiorum using transcriptomics and metagenomics.
Climate change is intensifying crop diseases, creating urgent demand for novel plant protection products. This research program focuses on Plant Growth-Promoting Rhizobacteria (PGPR) probiotics as a sustainable solution to fungal root rot in legumes, specifically targeting Sclerotinia sclerotiorum infection in Vicia faba L. (faba bean). The work builds on validated field results showing that PGPR inoculants can boost crop yields by 29-45%, and aims to identify the molecular mechanisms and targets behind these benefits, particularly during pathogen challenge. The goal is to enable the development of next-generation bio-based crop protection products.
Validated PGPR treatments include:
Experimental approach:
Planned next-phase validation:
The PGPR inoculants have been validated at field scale, demonstrating consistent and statistically significant yield improvements across two cultivars. The program is now advancing from agronomic validation toward mechanistic understanding and product-oriented development. The next stage involves controlled-pathogen trials combined with multi-omics analysis to elucidate resistance pathways and pinpoint molecular targets suitable for bio-product development. The team is actively seeking research funding, personnel support, and product development mentorship to advance toward commercialization.
The Centre for Research and Technology, Hellas (CERTH), founded in 2000, is a leading Greek research center that promotes the integration of research, development, and innovation. It comprises five specialized institutes focused on areas including chemical engineering, energy, environmental technology, and bio-economy. CERTH conducts high-quality basic and applied research and develops novel technologies through strong partnerships with industry and global academic institutions.